Discordance between nurse practitioner– or physician associate–reported and patient-reported atopic dermatitis severity and satisfaction with disease control and the relationship with patient-reported outcomes

Background: Data are limited on how nurse practitioners (NPs) and physician assistants (PAs) assess atopic dermatitis (AD) severity and treatment satisfaction and how their assessments compare to patient assessments. Purpose: To assess discordance between NPs or PAs and patients on assessments of AD severity and satisfaction with disease control, and relationship of discordance with patient-reported outcomes (PROs). Methodology: Data were collected from Adelphi Real World AD advanced practice providers Disease Specific Programme, a cross-sectional, real-world observational survey conducted in the United States from 2021 to 2022. Analysis included 87 NPs and PAs in dermatologist/allergist settings and 187 adult patients with current/history of moderate or severe AD. For each patient, NP or PA completed a form measuring subjective AD severity and satisfaction with disease control. Patients independently reported subjective assessments and completed validated PROs. Results: Among patient–NP and patient–PA dyads, 66% agreed on AD severity; in 22% of these dyads, NPs or PAs rated AD severity higher than the patient. Agreement on satisfaction with disease control occurred in 75% of dyads. Among those who disagreed, 17% of patients were more satisfied than NPs or PAs. Agreement on disease progression occurred in 57% of dyads. Discordant dyads were more likely to involve patients experiencing a flare, as assessed by NP or PA, and reporting greater PRO impairments. Conclusions: Most patient-NP and patient-PA dyads were concordant in AD assessments; however, a considerable proportion showed discordance. Discordance tended to be related to worse PROs. Implications: Alignment between patients and NPs or PAs in AD perceptions may improve outcomes.

Authors

Institutions

Publication Details

Journal
Journal of the American Association of Nurse Practitioners
Published
2026-11-19
DOI
https://doi.org/10.1097/jxx.0000000000001373
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Discordance between nurse practitioner– or physician associate–reported and patient-reported atopic dermatitis severity and satisfaction with disease control and the relationship with patient-reported outcomes

James Piercy, Simran Marwaha, Amber Reck Atwater, Lakshi M. Aldredge et al.
Journal of the American Association of Nurse Practitioners
Dermatology and Skin Diseases
article

Discordance between nurse practitioner– or physician associate–reported and patient-reported atopic dermatitis severity and satisfaction with disease control and the relationship with patient-reported outcomes

James Piercy, Simran Marwaha, Amber Reck Atwater, Lakshi M. Aldredge, Evangeline J. Pierce, Wendy Cantrell, Zach Dawson, Melissa M. Davis, Peter Anderson, Matthew Reynolds
article en

Abstract

Background: Data are limited on how nurse practitioners (NPs) and physician assistants (PAs) assess atopic dermatitis (AD) severity and treatment satisfaction and how their assessments compare to patient assessments. Purpose: To assess discordance between NPs or PAs and patients on assessments of AD severity and satisfaction with disease control, and relationship of discordance with patient-reported outcomes (PROs). Methodology: Data were collected from Adelphi Real World AD advanced practice providers Disease Specific Programme, a cross-sectional, real-world observational survey conducted in the United States from 2021 to 2022. Analysis included 87 NPs and PAs in dermatologist/allergist settings and 187 adult patients with current/history of moderate or severe AD. For each patient, NP or PA completed a form measuring subjective AD severity and satisfaction with disease control. Patients independently reported subjective assessments and completed validated PROs. Results: Among patient–NP and patient–PA dyads, 66% agreed on AD severity; in 22% of these dyads, NPs or PAs rated AD severity higher than the patient. Agreement on satisfaction with disease control occurred in 75% of dyads. Among those who disagreed, 17% of patients were more satisfied than NPs or PAs. Agreement on disease progression occurred in 57% of dyads. Discordant dyads were more likely to involve patients experiencing a flare, as assessed by NP or PA, and reporting greater PRO impairments. Conclusions: Most patient-NP and patient-PA dyads were concordant in AD assessments; however, a considerable proportion showed discordance. Discordance tended to be related to worse PROs. Implications: Alignment between patients and NPs or PAs in AD perceptions may improve outcomes.

Journal of the American Association of Nurse Practitioners
Eli Lilly (United States) (US), Adelphi Group (United Kingdom) (GB), VA Portland Health Care System (US), Associates in Neurology (US)
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon